Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05185739
Title Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) (PRIMER-1)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University College, London
Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Queen Elizabeth Hospital Not yet recruiting Birmingham United Kingdom Details
Cambridge University Hospitals NHS Foundation Trust Not yet recruiting Cambridge United Kingdom Details
Beatson West of Scotland Cancer Centre Not yet recruiting Glasgow United Kingdom Details
St James's Hospital, Leeds Teaching Hospital NHS Trust Not yet recruiting Leeds United Kingdom Details
Clatterbridge Cancer Centre Not yet recruiting Liverpool United Kingdom Details
King's College Hospital Not yet recruiting London United Kingdom Details
Royal Free Hospital Recruiting London United Kingdom Details
The Christie NHS Foundation Trust Not yet recruiting Manchester United Kingdom Details
Northern Institute of Cancer Research Not yet recruiting Newcastle Upon Tyne United Kingdom Details
*Shaded cells indicate that there was no data available from for the field